Latisse Alternatives Compared
Latisse | Bimatoprost topical | Fluorometholone ophthalmic |
|
---|
Latisse (bimatoprost) | Bimatoprost topical | Fluorometholone ophthalmic |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Eyelash Hypotrichosis. Latisse may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Eyelash Hypotrichosis. bimatoprost topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Eyelash Hypotrichosis, Eye Redness/Itching, Steroid Responsive Inflammatory Conditions, Allergies, Eye Redness. fluorometholone ophthalmic may also be used for purposes not listed in... View more |
Related suggestions Eyelash Hypotrichosis
|
|||||||||||||||||||||||
More about Latisse (bimatoprost) | More about Bimatoprost topical | More about Fluorometholone ophthalmic | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Latisse has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Bimatoprost topical has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fluorometholone ophthalmic has an average rating of 6.3 out of 10 from a total of 10 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Latisse side effects in more detail. |
See also: bimatoprost topical side effects in more detail. |
See also: fluorometholone ophthalmic side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Latisse prices |
View all bimatoprost topical prices |
View all fluorometholone ophthalmic prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Latisse | Eflone, Flarex, FML, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
0.75 hours |
0.75 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 5 drugs are known to interact with Latisse:
|
A total of 5 drugs are known to interact with bimatoprost topical:
|
A total of 42 drugs are known to interact with fluorometholone ophthalmic:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
December 24, 2008 |
N/A |
N/A |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.